home / stock / onppf / onppf short
Short Information | Oncopeptides (OTCMKTS:ONPPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,958 |
Total Actual Volume | 2,958 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 3 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 148 |
Average Short Percentage | 15.00% |
Is there a ONPPF Short Squeeze or Breakout about to happen?
See the ONPPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-04-2022 | $0.9 | $0.9 | $0.9 | $0.9 | 2,500 | 2,500 | 100% |
10-07-2021 | $3.15 | $3.15 | $3.15 | $3.15 | 200 | 200 | 100% |
12-16-2020 | $20.38 | $20.38 | $20.38 | $20.38 | 258 | 258 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Oncopeptides Company Name:
ONPPF Stock Symbol:
OTCMKTS Market:
FDA announces an Oncologic Drugs Advisory Committee meeting to discuss benefit/risk profile of Oncopeptides' Pepaxto PR Newswire STOCKHOLM , July 20, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on resear...
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this time PR Newswire STOCKHOLM , Jan. 21, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and deve...
Oncopeptides presents phase 3 OCEAN study results at the IMW meeting PR Newswire STOCKHOLM , Sept. 11, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat he...